Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMJGleeson Regulatory News (GLE)

Share Price Information for MJGleeson (GLE)

Share Price is delayed by 15 minutes
Get Live Data
245.00    0.00 (0.00%)
Bid:
245.00
Ask:
250.00
Spread: 5.00 (2.041%)
Market Cap: £142.92m
GLE Live PriceLast checked at - London Stock Exchange

Intraday MJGleeson Share Chart

Interim Management Statement

19 Nov 2013 07:00

RNS Number : 3443T
Gleeson(M J)Group PLC
19 November 2013
 



Gleeson (MJ) Group PLC

(GLE.L)

 

Interim Management Statement

 

Gleeson (GLE.L), the urban regeneration and strategic land specialist, announces its Interim Management Statement, covering the period from 1 July 2013 to 31 October 2013.

 

Gleeson has two divisions:

 

· Gleeson Homes An urban regeneration specialist in the North of England, with a particular focus on low cost family homes

 

· Gleeson Strategic Land A strategic land promotion business, mainly in the South of England, that enhances the value of land through the planning process and sells it to developers

 

Gleeson Homes

 

Gleeson Homes saw a strong performance during the period with 132 completions (2012: 60) and 253 reservations (2012: 150). With a forward order book currently comprising 275 units, the Board expects to record an increase in completions in the year to 30 June 2014 of not less than 25% against the prior year.

 

The business currently has 33 active sites, compared with 27 in the corresponding period. Gleeson Homes is in active discussions regarding the acquisition of a further 20 sites which, if purchased, will add 1,980 plots to the regeneration land pipeline, taking the total number of plots to in excess of 5,860.

 

Around 25% of completions during the period were achieved on a shared equity basis, with around 16% using the Government's "Help to Buy" initiative, a proportion which is expected to increase moderately as more of our customers choose to take advantage of this popular scheme.

 

Gleeson Strategic Land

 

Gleeson Strategic Land continued to perform in line with expectations during the period, enhancing its portfolio and progressing sites through the planning system. In line with increasing activity in the housing market, there has been a further improvement in the prices that developers are willing to pay for green field residential land in the South of England.

 

The business achieved planning permission on three sites which will deliver a combined total of 380 units. In addition, ten planning applications with the potential to deliver a total of 927 units were submitted during the period; and the business is also in negotiations regarding a further six sites, totalling 1,030 units.

 

The planning system continues, in some local authority areas, to be characterised by lengthy and unnecessary delays. Nonetheless, Gleeson Strategic Land expects to see a significant increase in the year to 30 June 2014 in total sales revenue compared to the prior year.

 

Outlook

 

The Board expects results for H1 2014 to show a strong increase over H1 2013. With an expected 25% increase in completions in Gleeson Homes overall in the current financial year, the Board now believes that the out-turn for the year to 30 June 2014 will significantly exceed current expectations.

 

 

19 November 2013

Enquiries:

MJ Gleeson Group plc

Tel: +44 1252 360 300

Jolyon Harrison

Chief Executive Officer

Alan Martin

Chief Financial Officer

College Hill

Tel: +44 20 7457 2020

Mark Garraway

Helen Tarbet

N+1 Singer

Shaun Dobson

Tel: +44 20 7496 3000

Jenny Wyllie

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSZMMMMLRLGFZM
Date   Source Headline
20th Feb 20189:37 amRNSHolding(s) in Company
19th Feb 20187:00 amRNSHalf-year Report
7th Feb 20184:40 pmRNSSecond Price Monitoring Extn
7th Feb 20184:35 pmRNSPrice Monitoring Extension
7th Feb 20182:21 pmRNSDirector/PDMR Shareholding
31st Jan 20187:00 amRNSTotal Voting Rights
10th Jan 20182:10 pmRNSDirector/PDMR Shareholding
4th Jan 20187:00 amRNSTrading Update
29th Dec 20177:00 amRNSTotal Voting Rights
8th Dec 201711:51 amRNSDirector/PDMR Shareholding
8th Dec 20178:53 amRNSDirector/PDMR Shareholding
7th Dec 20174:26 pmRNSResult of AGM
7th Dec 20177:00 amRNSAGM Statement
30th Nov 20177:00 amRNSTotal Voting Rights
23rd Nov 20175:48 pmRNSDirector/PDMR Shareholding
23rd Nov 20175:44 pmRNSHolding(s) in Company
8th Nov 20174:54 pmRNSDirector/PDMR Shareholding
8th Nov 20174:43 pmRNSHolding(s) in Company
8th Nov 20174:25 pmRNSDirector/PDMR Shareholding
6th Nov 20177:00 amRNSNotice of AGM
31st Oct 20177:00 amRNSTotal Voting Rights
6th Oct 20172:07 pmRNSDirector/PDMR Shareholding
4th Oct 201711:31 amRNSExercise of Options, TVR & Director/PDMR Dealings
29th Sep 20177:00 amRNSTotal Voting Rights
26th Sep 20174:06 pmRNSPerformance Share Plan Award to Directors
25th Sep 20177:00 amRNSFinal Results
8th Sep 20174:35 pmRNSPrice Monitoring Extension
7th Sep 20179:59 amRNSDirector/PDMR Shareholding
31st Aug 20177:00 amRNSTotal Voting Rights
23rd Aug 201712:07 pmRNSSecond Price Monitoring Extn
23rd Aug 201712:02 pmRNSPrice Monitoring Extension
22nd Aug 20174:35 pmRNSPrice Monitoring Extension
9th Aug 20179:13 amRNSDirector/PDMR Shareholding
31st Jul 20177:00 amRNSTotal Voting Rights
18th Jul 20174:55 pmRNSDirector/PDMR Shareholding
7th Jul 201710:06 amRNSDirector/PDMR Shareholding
5th Jul 20177:00 amRNSTrading Update
30th Jun 20177:00 amRNSTotal Voting Rights
6th Jun 20175:17 pmRNSDirector/PDMR Shareholding
31st May 20177:00 amRNSTotal Voting Rights
25th May 20171:27 pmRNSDirector/PDMR Shareholding
11th May 20171:11 pmRNSDirector/PDMR Shareholding
28th Apr 20177:00 amRNSTotal Voting Rights
24th Apr 20178:49 amRNSHolding(s) in Company
6th Apr 20176:11 pmRNSDirector/PDMR Shareholding
31st Mar 20177:00 amRNSTotal Voting Rights
7th Mar 20175:10 pmRNSDirector/PDMR Shareholding
3rd Mar 20176:14 pmRNSHolding(s) in Company
28th Feb 20177:00 amRNSTotal Voting Rights
27th Feb 20177:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.